1A). In the growth plate, high levels of Mepe mRNA were observed, especially in the hypertrophic chondrocytes ( Fig. 1B and C). This spatial expression pattern was further examined and quantified by microdissection of growth plates. To validate the microdissection technique, RT-qPCR of collagen type X mRNA expression was conducted to ensure that the hypertrophic zone could be considered as an enriched pool of hypertrophic

chondrocytes ( Fig. 1D). There was approximately a 10-fold increase in collagen type X mRNA expression in the hypertrophic zone in comparison to the Talazoparib nmr proliferative zone (P < 0.001). This is in concordance with previous studies done using a similar technique [31]. Mepe mRNA had a significantly higher expression (P < 0.05) selleck inhibitor in the hypertrophic zone in comparison to the proliferative zone of the growth plate ( Fig. 1E). Immunolocalization of MEPE and the MEPE-ASARM peptide in 4-week-old growth plates verified the in situ hybridization and microdissection data as

demonstrated by its localization to the hypertrophic zone of chondrocytes ( Fig. 1F and H). This ASARM peptide is cleaved from MEPE by cathepsin B; thus, we examined the immunolocalization of cathepsin B in the growth plate ( Fig. 1J). Here we show it to be expressed at the chondro-osseous junction as is in concordance with previous studies [32] and [33]. Representative images of the appropriate negative controls are shown ( Fig. 1G, I and K). Together these data indicate that MEPE-ASARM peptide is preferentially expressed by hypertrophic chondrocytes of the growth plate and this localization is consistent with a role for this peptide in regulating cartilage mineralization. It is known that the C-terminal fragment is the active form of MEPE. This fragment contains the ASARM peptide; thus, we next determined the role of the ASARM peptide in chondrocyte matrix mineralization by examining the mineralization capability of ATDC5 cells in response to MEPE-ASARM peptides. The ATDC5 cell RG7420 cell line line is a teratocarcinoma derived cell

line which has been shown to display the multistep chondrogenic differentiation process, from mesenchymal condensation to matrix mineralization [26] and [34], at approximately day 15 of culture. The culture method used here did not result in metabolic stress leading to cell death as indicated by assessment of released LDH activity as a percentage of total LDH release (0 mM βGP 33.5% ± 2.5, 10 mM βGP 35.2% ± 0.9, NS). Here we added pASARM and npASARM peptides to ATDC5 cell cultures under calcifying conditions over a 15-day culture period. There was no apparent morphological difference between control and ASARM-treated cells. pASARM peptides inhibited mineralization in a dose-dependent manner as visualised by alizarin red staining and quantified by spectrophotometry (at 20 μM and 50 μM in comparison to control; P < 0.01) ( Fig. 2A).